Nanosonics Ltd
ASX:NAN
Nanosonics Ltd
ASX:NAN
Price:
3.01 AUD
3.79%
Market Closed
Updated:
May 16, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
71.5
Current
147.9
Median
12.9
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=71.5
Enterprise Value
/
767.5m
EBITDA
10.7m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| AU |
|
Nanosonics Ltd
ASX:NAN
|
878.2m AUD | 71.5 | |
| CH |
|
Alcon AG
SIX:ALC
|
40B CHF | 20.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.8T JPY | 24.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
189.2B DKK | 25.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.1B USD | 25 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.5B USD | 24.2 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.4T KRW | -105.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.8B CNY | 29.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 46.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 11.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 10 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
59.4
2-Years Forward
EV/EBITDA
35.6
3-Years Forward
EV/EBITDA
25.7
You don't have any saved screeners yet
